tandospirone has been researched along with Cirrhosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, S; Huang, X; Jiang, X; Kang, Y; Mei, Q; Qin, D; Wu, AG; Wu, J; Yang, J; Ye, Y; Zhang, C | 1 |
1 other study(ies) available for tandospirone and Cirrhosis
| Article | Year |
|---|---|
Tandospirone enhances the anti-myocardial fibrosis effect of valsartan in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiomyopathies; Drug Synergism; Fibrosis; Gene Expression; Hypertension; Immunohistochemistry; Isoindoles; Male; Models, Biological; Myocardium; Piperazines; Pyrimidines; Rats; Rats, Inbred SHR; Serotonin Receptor Agonists; Smad3 Protein; Transforming Growth Factor beta; Valsartan | 2020 |